TABLE 2

Median Survival Time of Mice Treated with NaCl, Rituximab, 150 and 350 MBq/kg Concentrations of ¹⁷⁷Lu-Lilotomab and Combination Therapies with 20-mm Tumor Diameter as Endpoint

Treatment group	Median survival ± SE (d)
4×NaCl	13 ± 0
4 × 10 mg/kg rituximab	13 ± 3
150 MBq/kg ¹⁷⁷Lu-lilotomab	24 ± 4^*^†
350 MBq/kg ¹⁷⁷Lu-lilotomab	38 ± 11^*^†
150 MBq/kg ¹⁷⁷Lu-lilotomab + rituximab	31 ± 5^*^†
350 MBq/kg ¹⁷⁷Lu-lilotomab + rituximab	70 ± 8^*^†

↵* Significantly different from NaCl (P < 0.001).
↵† Significantly different from 4 × 10 mg/kg rituximab (P < 0.01).